ChoA Pharmaceutical Co.Ltd (034940) — Cash Flow Reinvestment Rate
ChoA Pharmaceutical Co.Ltd (034940) has a Cash Flow Reinvestment Rate of 2.22x as of September 2025, reinvesting ₩2.80 Billion (capex ₩324.67 Million plus investments ₩-2.48 Billion) from operating cash flow of ₩1.26 Billion. Explore 034940 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ChoA Pharmaceutical Co.Ltd Cash Flow Reinvestment Rate (2004–2020)
Historical reinvestment intensity for ChoA Pharmaceutical Co.Ltd across 8 annual periods. Also explore 034940 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for ChoA Pharmaceutical Co.Ltd (2004–2020)
Year-by-year capital reinvestment analysis for ChoA Pharmaceutical Co.Ltd. For live market cap and broader valuation context, see 034940 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 1.89x | ₩3.63 Billion | ₩1.92 Billion | ₩3.60 Billion | ▲ +248.0% |
| 2019 | 0.54x | ₩2.25 Billion | ₩4.16 Billion | ₩1.39 Billion | ▼ -62.6% |
| 2018 | 1.45x | ₩2.96 Billion | ₩2.04 Billion | ₩1.97 Billion | ▼ -56.1% |
| 2016 | 3.30x | ₩3.07 Billion | ₩930.42 Million | ₩2.30 Billion | ▲ +26.5% |
| 2015 | 2.61x | ₩3.10 Billion | ₩1.19 Billion | ₩1.78 Billion | ▼ -72.7% |
| 2014 | 9.55x | ₩5.97 Billion | ₩625.52 Million | ₩5.64 Billion | ▲ +3059.9% |
| 2013 | 0.30x | ₩1.07 Billion | ₩3.53 Billion | ₩1.07 Billion | ▲ +110.8% |
| 2004 | 0.14x | ₩512.47 Million | ₩3.57 Billion | ₩512.47 Million | — |